Results 91 to 100 of about 10,636 (185)
Neuroleptic Malignant Syndrome Caused by a Combination of Carbamazepine and Amitriptyline
Case Reports in Neurological Medicine, 2012 A 32-year-old female, with a history of secondarily-generalized convulsive epilepsy, mental retardation, and a psychiatric illness, developed neuroleptic malignant syndrome while receiving carbamazepine and amitriptyline concurrently. We hypothesize that
A. Bruce Janati +2 more
doaj +1 more source
Antipsychotics in the treatment of psychosis: risks and benefits [PDF]
, 2013 Antipsychotics are important in the treatment and recovery of people with psychosis but current evidence suggests that mental health nurses are not always conversant with the risks and benefits of these drugs.
Bressington, D., Mutsatsa, S.
core +1 more source
THE ROLE OF CYP2D6 AND TAQI A POLYMORPHISMS IN MALIGNANT NEUROLEPTIC SYNDROME: TWO CASE REPORTS WITH THREE EPISODES [PDF]
, 2010 Malignant neuroleptic syndrome (MNS) is a serious and potentially fatal side-effect of neuroleptic treatment. Beside antipsychotic drugs, other psychotropic drugs such as antidepressants and lithium carbonate can cause this life threatening sideeffect ...
Alma Mihaljević-Peleš +4 more
core +1 more source
Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review [PDF]
, 2017 The use of antipsychotics to manage challenging behaviour in adults with intellectual disability is widespread but controversial, and evidence is scarce.
Hassiotis, A, Sheehan, R
core +1 more source
The Turkish Journal of Pediatrics, 1996 Neuroleptic malignant syndrome, the most serious and potentially fatal side effect of neuroleptics, is characterized by altered consciousness, extrapyramidal symptoms, hyperthermia, elevated plasma creatine phosphoidnase and leukocytosis.
F Unal, S Hizli, H Ozyürek, B Sonuvar
doaj
Neuroleptic malignant syndrome: need for early diagnosis and therapy [PDF]
, 2006 Background: Neuroleptic Malignant Syndrome (NMS) is a medical entity that has received little attention in the clinical settings in Pakistan. The aim of our study was to review the predisposing factors, outcomes and characteristics of in-patients ...
Kamal, Ayeesha +5 more
core +1 more source
Neuroleptic malignant syndrome: the diagnostic dilemma
Open Journal of Psychiatry and Allied Sciences, 2016 Neuroleptic malignant syndrome (NMS) is a life-threatening, often fatal idiosyncratic reaction to neuroleptic or other drug therapies that antagonise the central dopaminergic neurotransmission. The clinical presentation of NMS is very heterogeneous.
Ivana Stasevic Karlicic +5 more
doaj +1 more source
Retrospective chart review of catatonia in child and adolescent psychiatric patients [PDF]
, 2012 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/89509/1/j.1600-0447.2011.01778.x ...
Abrams +31 more
core +1 more source
ADVERSE DRUG REACTIONS OF PSYCOPHARMACS [PDF]
, 2010 Background: The objective of analysis of ADRs caused by drugs that pertain to the ATC group N (nervous system), as reported to the Croatian Agency for Medicinal Products and Medical Devices for the period from March 2005 to December 2008, was to examine ...
Darko Krnić +7 more
core +1 more source
Movement Disorders Presenting in Childhood. [PDF]
, 2016 PURPOSE OF REVIEW: This article provides an overview of movement disorders that present in childhood. Key clinical features are discussed, and a brief guide to management strategies is provided.
Dale, RC, Kurian, MA
core +1 more source